No Data
No Data
Vera Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Vera Therapeutics Insider Sold Shares Worth $753,680, According to a Recent SEC Filing
Vera Therapeutics (VERA) Receives a Buy From TD Cowen
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics Price Target Announced at $70.00/Share by Wells Fargo
Unlock the Full List